PUBLICATIONS

2010 - 2016

  • V. Lee, Sum-Yin Chan, Cheuk-Wai Choi, D. Kwong, Ka-On Lam, Chi-Chung Tong, Chun-Kin Sze, S. Ng, To-Wai Leung, A. Lee. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma. Clinical Oncology (Royal College of Radiologists), DOI: http://dx.doi.org/10.1016/j.clon.2016.05.004.

  • Ng WT, Chang AT, Lee SW, Sze HC, Lee AW.* Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant. Curr Treat Options Oncol. Sep;16(9):361, 2015

  • Sze HCK, Lee AWM, Blanchard P, Ng WT, Pignon JP. Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies. Hematology/Oncology Clinics of North America, 29:1107-1122, 2015

  • Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AWM, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review. Head Neck, DOI: 10.1002/hed.24026, 2015

  • Yang X, Dai W, Kwong DL, Szeto CYY, Wong EH, Ng WT, Lee AWM, Ngan RKC, Yau CC, Tung SY, Lung ML. Epigenetic markers for non-invasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. IJC, DOI: 10.1002/ijc.29192, 2015

  • Kan R, Shuen WH, Lung HL, Cheung AKL, Dai W, Kwong DLW, Ng WT, Lee AWM, Yau CC, Ngan RKC, Tung SY, Lung ML. NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding. PLOS ONE | DOI:10.1371/journal.pone.0127239 (2015)

  • Lee A,* Ngan R, Tung S, Cheng A, Kwong D, Lu TX, Chan A, Chan L, Yiu H, Ng WT, Wong F, Yuen KT, Yau S, Cheung FY, Chan O, Choi H, Chappell R. Preliminary Results of NPC-0501 Trial to Evaluate the Therapeutic Gain by Changing Chemoradiotherapy Sequence from Concurrent-Adjuvant to Induction-Concurrent, Fluorouracil to Capecitabine, and Radiotherapy Fractionation from Conventional to Accelerated for Locoregionally Advanced Nasopharyngeal Carcinoma. Cancer, 121:1328-38, 2015

  • Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AWM, Haigentz M Jr, Beitler JJ, de Bree R, Takes RP, Paleri V, Kelly CG, Genden EM, Bradford CR, Harrison LB, Rinaldo A, Ferlito A. Recurrent and Second Primary Squamous Cell Carcinoma of the Head And Neck: When and How to Re-Irradiate. Head & Neck, 37(1):134-150, 2015

  • AWM Lee,* B Ma, WT Ng, ATC Chan. The management of nasopharyngeal carcinoma – current practice and future perspective. JCO, 33.3356-3364, 2015

  • Chan KC, Chan LS, Ip JCY, Lo C, Yip TTC, Ngan RKC, Wong RNS, Lo KW, Ng WT,Lee AWM, Tsao GSW, Kahn M, Lung ML, Mak NK. Therapeutic targeting of CBP/b-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Scientific Reports 5 : 9979 | DOI: 10.1038/srep09979 (2015)

  • Yuan C, Yip SP, Wu VW, Kwong DL, Cheuk IW, Ying M. Association between genetic polymorphisms and carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma. Radiat Oncol. 2015;10:39.

  • Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015 Jun;16(6):645-55.

  • Li JY, Pow EH, Zheng LW, Ma L, Kwong DL, Cheung LK. Effects of calcium phosphate nanocrystals on osseointegration of titanium implant in irradiated bone. Biomed Res Int. 2015;2015:783894.

  • Chen J, Kwong DL, Cao T, Hu Q, Zhang L, Ming X, Chen J, Fu L, Guan X. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Dis Esophagus 28 (1): 84-9, 2015

  • Chan MK, Kwong DL, Lee VW, Leung RW, Wong MY, Blanck O. Feasibility study of robotic hypofractionated lung radiotherapy by individualized internal target volume and XSight Spine Tracking: a preliminary dosimetric evaluation. J Cancer Res Ther. 2015 Jan-Mar;11(1):150-7.

  • Huang B, Wong CY, Lai V, Kwong DL, Khong PL. Prognostic Value of (18) F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful? Biomed Res Int. 2015;2015:582614.

  • Lung HL, Man OY, Yeung MC, Ko JM, Cheung AK, Law EW, Yu Z, Shuen WH, Tung E, Chan SH, Bangarusamy DK, Cheng Y, Yang X, Kan R, Phoon Y, Chan KC, Chua D, Kwong DL, Lee AW, Ji MF, Lung ML. SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma. Oncogene. 2015 Feb 12;34(7):878-89.

  • Yuan C, Wu VW, Yip SP, Kwong DL, Ying M. Ultrasound Evaluation of Carotid Atherosclerosis in Post-Radiotherapy Nasopharyngeal Carcinoma Patients, Type 2 Diabetics, and Healthy Controls.Ultraschall Med. 2015 Apr 1. (Epub ahead of print)

  • Seneviratne CJ, Fong PHL, Wong SSW, Lee VHF. Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy. BMC Oral Health 2015 (accepted for publication)

  • Hui EP, Ma BBY, Chan KCA, Chan CML, Wong CSC, To KF, Chan AWH, Tung SY, Ng WT, Cheng AC, Lee VHF, Chan SL, Loong HHF, Kam MKM, Leung SF, Ho R, Mo F, Lo DYM, Ngan RKC, Chan ATC. Clinical utility of plasma EBV DNA andERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma. Cancer 2015 (accepted for publication)

  • Dai W, Cheung AKL, Ko JMY, Cheng Y, Zheng H, Ngan RKC, Ng WT, Lee AWM, Yau CC, Lee VHF, Li Lung M. Comparative Methylome Analysis in Solid Tumours Reveals Aberrant Methylation at Chromosome 6p in Nasopharyngeal Carcinoma. Cancer Med (accepted for publication)

  • Wang DD, Ma LC, Wong MP, Lee VHF, Yan H. Contribution of IGF-1R to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments. PLoS One (Submitted for publication)

  • Lee VHF , Leung DKC, Choy TS, Lam KO, Choi HY, Lam PM, Hui CYT, Leung TW,Kwong DLW. Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small cell lung cancer previously responsive to 1st generation tyrosine-kinase inhibitors and chemotherapy: comparison with historical cohort using erlotinib in the same setting. Lung Cancer (Submitted for publication)

  • Ma LC, Wang DD, Huang YQ, Yan H, Wong MP, Lee VHF. EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib. BMC Bioinformatics 2015;16:85 (Epub ahead of print) DOI: 10.1186/s12859-015-0522-3

  • Lee EYP, Khong PL, Lee VHF, Qian WS, Wong MP. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation. Clin Nucl Med 2015;40(3):e190-195. doi: 10.1097/RLU.0000000000000684

  • Yu VZ, Wong VCL, Mun-Yee Ko JMY, Lam AKY, Chan KW, Samant R, Hong Lok Lung HL, Dai W, Shuen WH, Law S, Chan YP, Lee NPY, Tong DKH, Law TT, Lee VHF, Li Lung M. Nuclear DNAJB6, a good independent prognostic marker for survival of late-onset metastasis-free esophageal cancer patients, modulates Akt signaling and suppresses cancer cell proliferation. Gastroenterology (submitted for publication)

  • Lee VHF , Kwong DLW, Leung TW, Choi CW, Lam KO, Sze HCK, Ho PPY, Chan WL, Wong LS, Leung DKC, Chan SY, Chan FT. Postradiation plasma EBV DNA and local clinical remission after radical intensity-modulated radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 2015 (submitted for publication)

  • Lee VHF (first and corresponding author), Leung DKC, Luk MY, Tong CC, Law MWM, Ng SCY, Tso WK, Wong KK, Liu RKY, Roon RTP, Kwong DLW, Leung TW. Yttrium-90 Radioembolization for Advanced Inoperable Hepatocellular Carcinoma. Asian Pac J Cancer Prev (Submitted for publication)

  • Lee AWM,* Sze H, Lam KO, Chen X.A Tale Of Two Cities In China: Hong Kong And Shenzhen. Int J Radiat Oncol Biol Phys, 89(4):704-708, 2014

  • Kam MKM, Wong FCS; Kwong DLW; Sze HCK, Lee AWM. Current Controversies in Radiotherapy for Nasopharyngeal Carcinoma (NPC). Oral Oncol, 50(10):907-912, 2014

  • Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting CK, O’Sullivan B, Porceddum SV, Lengele B. Delineation of the Neck Node Levels for Head and Neck Tumors: A 2013 Update. DAHANCA, EORTC, HKNPCSF, NCIC, CTG, NCRI, RTOG, TROG Consensus Guidelines. Radiother Oncol, 110(1):172-181, 2014

  • Lee AWM,* Ng WT, Chan LLK, Hung WM, Chan CCC, Sze HCK, Chan OSH, Chang ATY, Yeung RM. Evolution of Treatment for Nasopharyngeal Cancer - Success and Setback in the Intensity-Modulated Radiotherapy Era. Radiother Oncol, 110(3):377-384, 2014

  • Sun Y, Yu XL, Lee AWM, Wee JTS, Lee N Zhou GQ, Tang LL, Tao CJ, Guo R, Mao YP, Zhang R, Guo Y, Ma J. Recommendation for a Contouring Method and Atlas of Organs at Risk in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy. Radiother Oncol, 110(3):390-397, 2014

  • Sze H, Chan LLK., Ng WT, Hung AWM, Lee MCH, Chang ATY, Chan OSH, Cheung FY, Yeung RMW, Lee AWM. Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4? Oral Oncol 50:1188–1195; 2014

  • Ng WT, Yuen KT, Au KH, Chan OSH, Lee AWM. Staging of Nasopharyngeal Carcinoma - The Past, The Present and The Future. Oral Oncol, 50(6):549-554, 2014

  • Ng WT, Lee MCH, Chang ATY, Chan OSH, Chan LLK, Cheung FY, Hung WM, Chan CC, Lee AWM. The Impact of Dosimetric Inadequacy on Treatment Outcome of Nasopharyngeal Carcinoma with IMRT. Oral Oncol, 50(5):506-512, 2014

  • Cheuk IW, Yip SP, Kwong DL, Wu VW. Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinoma. Mol Clin Oncol. 2014 Jul;2(4):553-558.

  • Shan J, Pow EH, Tsang PC, Perera RA, Kwong DL. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients. J Investig Clin Dent. 2014 May;5(2):104-8.

  • Li JY, Pow EH, Zheng LW, Ma L, Kwong DL, Cheung LK. Dose-dependent effect of radiation on titanium implants; a quantative study in rabbits. Clin Oral Implants Res. 2014; 25(2):260-5.

  • EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, WangY, Wang Z, Darby S. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014 Jun 21;383(9935):2127-35.

  • Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK. Genomic diversity of epstein-barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol. 2014 Sep 15;88(18):10662-72.

  • Yee Ko JM, Dai W, Wun Wong EH, Kwong D, Tong Ng W, Lee A, Kai Cheong Ngan R, Chung Yau C, Tung S, Li Lung M. Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair. Int J Cancer. 2014 Oct 1;135(7):1634-45.

  • Yuan C, Wu VW, Yip SP, Kwong DL, Ying M. Predictors of the extent of carotid atherosclerosis in patients treated with radiotherapy for nasopharyngeal carcinoma. PLoS One. 2014 Dec 31;9(12):e116284.

  • Li JY, Pow EH, Zheng LW, Ma L, Kwong DL, Cheung LK. Quantitative analysis of titanium-induced artifacts and correlated factors during micro-CT scanning. Clin Oral Implants Res. Clin Oral Implants Res. 2014 Apr;25(4):506-10.

  • Cheng SC, Wu VW, Kwong DL, Lui CY, Cheng AC, Kot BC, Ying MT. Sonographic appearance of thyroid glands in patients treated with intensity-modulated radiotherapy or conventional radiotherapy for nasopharyngeal carcinoma. J Clin Ultrasound. 2014 Aug 19. (Epub ahead of print)

  • Liu AP, Shing MM, Yuen HL, Li CH, Ling SC, Luk CW, Ha SY, Li CK, Kwong DL, Chan GC. Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma.Pediatr Blood Cancer. 2014; 61(4):606-11.

  • Chan WL, Lee VH, Siu WK, Ho PY, Liu RK, Leung TW. Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers. South Asian J Cancer. 2014 Jul;3(3):175-8. doi: 10.4103/2278-330X.136802.

  • Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD 3rd, Chen K, Wang JC, Wen W, Cawthon R, Chatterjee N, Hu W, Caporaso NE, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein RJ, Chung CC, Oh IJ, Chen KY, Berndt SI, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Chen YM, Liu L, Hyun Kang C, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Dart Loon Sihoe A, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen RC, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Pik Wong M, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni Jr JF, Zheng W, Lin D, Chanock SJ, Rothman N, Lan Q. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia. Int J Cancer. 2014 Dec 16. doi: 10.1002/ijc.29393.

  • Lee VHF, Fang WJ, Lam KO, Choi CW, Ng SCY, Ho GCL, Cheng TKC, Ho PPY, Liu RKY, Leung TW, Kwong DLW, Zheng SS. Impact of CAPOX or FOLFOX on spleen size, platelet count and liver function when partnered cetuximab as first-line treatment for KRAS wild-type metastatic colorectal cancer. Cancer Research Frontiers (accepted for publication)

  • Chan WL, Lee VHF, Siu SWK, Leung TW. Inoperable Adenoid Cystic Carcinoma of Trachea: Complete Remission after Multi-modality Treatment. Hong Kong J Radiol 2014;17:203-7. doi: 10.12809/hkjr1413202

  • Lai V, Lee VH, Lam KO, Sze HC, Chan Q, Khong PL. Intravoxel water diffusion heterogeneity MR imaging of nasopharyngeal carcinoma using stretched exponential diffusion model. Eur Radiol. 2014 Dec 23.

  • Lai V, Li X, Lee VH, Lam KO, Fong DY, Huang B, Chan Q, Khong PL. Nasopharyngeal carcinoma: comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging. Eur Radiol 2014;24:176-183.

  • Tsang JWH, Lee VHF, Kwong DLW. Novel therapy for nasopharyngeal carcinoma – Where are we. Oral Oncol 2014;50(9):798-801. doi: 10.1016/j.oraloncology.2014.01.002.

  • Lee VHF , Chan WWL, Lee EYP, Choy TS, Ho PPY, Leung DKC, Lam KO, Kwong DLW, Leung TW, Khong PL. Prognostic significance of standardized uptake value of lymph nodes on survival for stage III non-small-cell lung cancer treated with definitive concurrent chemoradiotherapy. Am J Clin Oncol 2014

  • Mok TS, Geater SL, Iannotti N, Thongprasert S, Spira A, Smith D, Lee V, Lim WT, Reyderman L, Wang B, Gopalakrishna P, Garzon F, Xu L, Reynolds C. Randomised phase II study of two intercalated combinations of eribulin mesilate and erlotinib in patients previously pretreated advanced non-small cell lung cancer. Ann Oncol 2014;25(8):1578-84. doi: 10.1093/annonc/mdu174

  • Chung JCK, Lee VHF , Tsang RKY, Chan JYW, Kwong DLW, Lam KO, Sze HCK, Leung TW. Treatment outcomes of post-radiation second head and neck malignancies (PRT-SHNM) managed by a multidisciplinary approach. Head Neck 2014 doi: 10.1002/hed.23674

  • Wong KW, Kwong DLW, Khong PL, Lee VHF, Ng SCY, Law MWM. Delineation of biological tumor volume from positron emission tomography images in nasopharyngeal carcinoma. J. Biomedical Science and Engineering 2014;7:857-865. (Impact factor: 1.180; 5-year impact factor: not available; number of citations: 0)

  • Cheng AL, Li J, Vaid AK, Ma BB, TheC, Ahn JB, Bello M, Charoentum C, Chen LT, de Lima Lopes G Jr, Ho GF, Kong HL, Lam KO, Liu TS, Park YS, Sriuranpong V, Sudoyo AW, Wang JY, Zhang J, Zhang SZ, Ciardiello F, Kohne CH, Shaw M, Kim TW. Adaptation of international guidelines for metastatic colorectal cancer: an Asian consensus. Clin Colorectal Cancer. 2014;13:145-55

  • Lam KO, Law BTT, Law SYK, Kwong DLW. Intraperitoneal chemotherapyfor gastric cancer with peritoneal carcinomatosis: is HIPEC the only answer? Modern Chemotherapy. 2014;3:11-19. Doi:10.4236/mc.2014.32003.

  • Lai V, Lee VH, Lam KO, Sze HC, Chan Q, Khong PL. Intravoxel water diffusion heterogeneity MR imaging of nasopharyngeal carcinoma using stretched exponential diffusion model. Eur Radiol. 2014 Dec 23.

  • Chan KC, Ting CM, Chan PS, Lo MC, Lo KW, Curry JE, Smyth T, Lee AWM, Ng WT, Tsao GSW, Wong RNS, Lung ML, Mak NK. A Novel HSP90 Inhibitor AT13387 Induces Senescence in EBV-Positive Nasopharyngeal Carcinoma Cells and Suppresses Tumor Formation. Molecular Cancer, 12, 2013

  • Chan OSH, Yeung RMW, Lee AWM. Maintenance Therapy in Advanced Non-Small Cell Lung Cancer: A Prime-Time for Change? Chin Med J, 126(12):2390-2398, 2013

  • Lee AWM,* Sze H, Ng WT. Is Selective Neck Irradiation Safe for Node-Negative Nasopharyngeal Carcinoma? Int J Radiat Oncol Biol Phys, 85(4):902-903, 2013

  • Luk YS, Shum JSF, Sze HCK, Chan LLK, Ng WT, Lee AWM. Predictive Factors and Radiological Features of Radiation-Induced Cranial Nerve Palsy in Patients with Nasopharyngeal Carcinoma following Radical Radiotherapy. Oral Oncol, 49(1):49-54, 2013

  • Lau HY, Leung CM, Chan YH, Lee AWM, Kwong DLW, Lung ML, Lam TH. Secular Trends of Salted Fish Consumption and Nasopharyngeal Carcinoma: A Multi-Jurisdiction Ecological Study in 8 Regions from 3 Continents. BMC Cancer, 13:298, 2013

  • Wong CK, Lam CL, Poon JT, Kwong DL. Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms. PLoS One. 2013; 8(3): e58341.

  • Wong CK, Lam CL, Law WL, Poon JT, Kwong DL, Tsang J, Wan YF. Condition-specific measure was more responsive than generic measure in colorectal cancer: all but social domains. J Clin Epidemiol. 2013; 66(5): 557-65.

  • D’cruz A, Lin T, Anand AK, Atmakusuma D, Calaguas MJ, Chitapanarux I, Cho BC, Goh BC, Guo Y, Hsieh WS, Hu C, Kwong D, Lin JC, Lou PJ, Lu T, Prabhash K, Sriuranpong V, Tang P, Vu VV, Wahid I, Ang KK, Chan AT. Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines. Oral Oncol. 2013 Sep;49(9):872-7.

  • Chan MK, Kwong DL, Law GM, Tam E, Tong A, Lee V, Ng SC. Dosimetric evaluation of four-dimensional dose distributions of CyberKnife and volumetric-modulated arc radiotherapy in stereotactic body lung radiotherapy. J Appl Clin Med Phys. 2013 Jul 8;14(4):4229.

  • Huang B, Wong CS, Whitcher B, Kwong DL, Lai V, Chan Q, Khong PL. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol. 2013;23(6):1495-502.

  • Chan MK, Kwong DL, Tong A, Tam E, Ng SC. Evaluation of dose prediction error and optimization convergence error in four-dimensional inverse planning of robotic stereotactic lung radiotherapy.J Appl Clin Med Phys. 2013; 14(4):4270.

  • Chan MK, Kwong DL, Ng SC, Tong AS, Tam EK. Experimental evaluations of the accuracy of 3D and 4D planning in robotic tracking stereotactic body radiotherapy for lung cancers. Med Phys. 2013; 40(4): 041712.

  • Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805-16.

  • Wong CK, Lam CL, Mulhern B, Law WL, Poon JT, Kwong DL, Tsang J. Measurement invariance of the Functional Assessment of Cancer Therapy-Colorectal quality-of-life instrument among modes of administration.Qual Life Res. 2013; 22(6): 1415-26.

  • Tian F, Yip SP, Kwong DL, Lin Z, Yang Z, Wu VW. Promotor hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Cancer Epidemiol. 2013; 37(5):708-13.

  • Chan MK, Kwong DL, Tam E, Tong A, Ng SC. Quantifying variability of intrafractional target motion in stereotactic body radiotherapy for lung cancers. J Appl Clin Med Phys. 2013; 14(5):140-52.

  • Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, Qi L, Li Y, Zhang N, Tong AH, Kwong DL, Man K, Lo CM, Lok S, Tenen DG, Guan XY. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med. 2013;19(2):209-16.

  • Lo MC, Yip TC, Ngan KC, Cheng WW, Law CK, Chan PS, Chan KC, Wong CK, Wong RN, Lo KW, Ng WT, Lee WM, Tsao SW, Kwong LW, Lung ML, Mak NK. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett. 2013 Jul 10;335(1):81-92.

  • Cheng SC, Ying MT, Kwong DL, Wu VW. Sonographic appearance of submandibular glands in patients treated with external beam radiotherapy for nasopharyngeal carcinoma. J Clin Ultrasound. 2013; 41(8):472-8.

  • Ying M, Zheng YP, Kot BC, Cheung JC, Cheng SC, Kwong DL. Three-dimensional elastography for cervical lymph node volume measurements: a study to investigate feasibility, accuracy and reliability. Ultrasound Med Biol. 2013;39(3):396-406.

  • Lee VH, Tin VP, Choy TS, Lam KO, Choi CW, Chung LP, Tsang JW, Ho PP, Leung DK, Ma ES, Liu J, Shek TW, Kwong DL, Leung TW, Wong MP. Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non-Small-Cell Lung Cancer. J Thorac Oncol 2013;8:1148-1155.

  • Lam KO, Lee VH, Liu RK, Leung TW, Kwong DL. Bevacizumab-containing regimens after cetuximab failure in Kras wild-type metastatic colorectal carcinoma. Oncol Lett. 2013 Feb;5(2):637-640.

  • Lee VW, Schwander B, Lee VH. Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong. Hong Kong Med J. 2013; Nov 22. doi: 10.12809/hkmj133986.

  • Wu YL, Lee JS, Thongprasert S, Yu CJ, Zhang L, Ladrera G, Srimuninnimit V, Sriuranpong V, Sandoval-Tan J, Zhu Y, Liao M, Zhou C, Pan H, Lee V, Chen YM, Sun Y, Margono B, Fuerte F, Chang GC, Seetalarom K, Wang J, Cheng A, Syahruddin E, Qian X, Ho J, Krunianda J, Liu HE, Jin K, Truman M, Bara I, Mok T. Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-lung cancer (FASTACT-2): a randomised, double-blind trial. Lancet Oncol 2013;14:777-786.

  • Lai V, Li X, Lee VH, Lam KO, Chan Q, Khong PL. Intravoxel incoherent motion MR imaging: comparison of diffusion and perfusion characteristics between nasopharyngeal carcinoma and post-chemoradiation fibrosis. Eur Radiol 2013;23(10):2793-2801.

  • Fang W, Lam K, Ng S, Choi C, Kwong D, Zeng S, Lee V. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST. Asian Pac J Cancer Prev 2013;14(7):4151-5.

  • Zhang LY, Lee VHF, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 2013 Feb;34(2):454-63.

  • Lee VHF, Kwong DLW. Palliative Chemotherapy and Targeted Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma: Reminiscences and the Future. Hong Kong J Radiol 2013;16:252-260. DOI: 10.12809/hkjr1313185.

  • Ng SC, Lee VH, Law MW, Liu RK, Ma VW, Tso WK, Leung TW. Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging. J Appl Clin Med Phys 2013 Sep 6;14(5):4371.

  • Wang DD, Zhou W, Yan H, Wong M, Lee V. Personalized prediction of EGFR mutation-induced drug resistance in lung cancer. Sci Rep. 2013 Oct 4;3:2855.

  • Lam KO. From complexity to simplicity: best level of evidence for metastatic colorectal cancer. Hong Kong J Radiol. 2013;16(4)Suppl:S9-16.

  • Fang WJ, Lam KO, Ng SC, Choi CW, Kwong DL, Zheng SS, Lee VH. Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST. Asian Pac J Cancer Prev. 2013;14:4151-5

  • Yau TK, Shum T, Lee AWM, Yeung MW, Ng WT, Chan L. A Phase II Study of Pemetrexed Combined with Cisplatin in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma. Oral Oncol, 48(5):441-444, 2012

  • Lee AWM,* Lin JC, Ng WT. Current Management of Nasopharyngeal Cancer. Seminar in Radiat Oncol, 22(3):233-244, 2012

  • Lee AWM,* Ng WT, Chan OSH, Sze H. If Concurrent- Adjuvant Chemoradiotherapy is Beneficial for Locoregionally Advanced Nasopharyngeal Carcinoma, would Changing the Sequence to Induction-Concurrent Achieve Better Outcome? Radiat Oncol, 1(2):107-115, 2012

  • Chen H, Ko JMY, Wong VCL, Hyytiainen M, Keski-Oja J, Chua D, Nicholls JM, Cheung FMF, Lee AWM, Kwong DLW, Chiu PM, Zabarovsky ER, Tsao SW, Tao Q, Kan R, Chan SHK, Stanbridge EJ, Lung ML. LTBP-2 Confers Pleiotropic Suppression and Promotes Dormancy in a Growth Factor Permissive Microenvironment in Nasopharyngeal Carcinoma. Cancer Lett, 325(1):89-98, 2012

  • Lee AWM,* Fee WE Jr, Ng WT, Chan LK. Nasopharyngeal Carcinoma: Salvage of Local Recurrence. Oral Oncol, 48(9):768-774, 2012

  • Sze HCK, Ng WT, Chan OSH, Shum TCY, Chan LLK, Lee AWM. Radical Radiotherapy For Nasopharyngeal Carcinoma In Elderly Patients: The Importance Of Co-Morbidity Assessment. Oral Oncol,48(2):162-167,2012

  • Sze HCK, Lee MCH, Hung WM, Yau TK, Lee AWM. Rapidarc Radiotherapy Planning for Prostate Cancer: Single-Arc and Double-Arc Techniques vs. Intensity-Modulated Radiotherapy. Med Dosimetry, 37(1):87-91, 2012

  • Ting CM, Wong CKC, Wong RNS, Lo KW, Lee AWM, Tsao GSW, Lung ML, Mak NK. Role of STAT3/5 and BCL-2/Xl in 2-Methoxyestradiol-Induced Endoreduplication of Nasopharyngeal Carcinoma Cells. Molecular Carcinogenesis, 51(12):963-972, 2012

  • Chan OSH, Yeung RMW, Hung AWM, Lee MCH, Chang ATY, Chan CCC, Lee AWM. Stereotactic Ablative Radiotherapy for Medically Inoperable Early Stage Lung Cancer: Early Outcomes. HK Med J, 18(5):412-418, 2012

  • Lee AWM,* Ng WT, Chan YH, Sze H, Chan C, Lam TH. The Battle Against Nasopharyngeal Cancer. Radiother Oncol, 104(3):272-278, 2012

  • Cheung F, Chan O, Ng WT, Chan L. Lee A, Pang SW. The Prognostic Value of Histological Typing in Nasopharyngeal Carcinoma. Oral Oncol, 48(5):429-433, 2012

  • Lee AWM,* Ng WT, Chan LK, Chan OSH, Hung WM, Chan CC, Cheng PTC, Sze H, Lam TS, Yau TK. The Strength/Weakness of the AJCC/UICC Staging System (7Th Edition) for Nasopharyngeal Cancer and Suggestions for Future Improvement. Oral Oncol, 48(10):1007-1013, 2012

  • Law ALY, Ng WT, Lee MCH, Chan ATS, Fung KH, Li F, Lao WC, Lee AWM. Treatment of Primary Liver Cancer Using Highly-Conformal Radiotherapy with KV-Image Guidance and Respiratory Control. Radiother Oncol, 102(1):56-61, 2012

  • Huang Z, Cheng Y, Chiu PM, Cheung FMF, Nicholls JM, Kwong DLW, Lee AWM, Zabarovsky ER, Stanbridge EJ, Lung HL, Lung ML. Tumor Suppressor Alpha B-Crystallin (CRYAB) Associates with the Cadherin/Catenin Adherens Junction and Impairs NPC Progression-Associated Properties. Oncogene, 31(32):3709-3720, 2012

  • Cheng HC, Wu VW, Ngan RK, Tang KW, Chan CC, Wong KH, Au SK, Kwong DL. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Radiother Oncol 2012; 104(3): 317-23.

  • Chan MK, Kwong DL, Ng SC, Tong AS, Tam EK. Accuracy and sensitivity of four-dimensional dose calculation to systematic motion variability in stereotatic body radiotherapy (SBRT) for lung cancer. J Appl Clin Med Phys. 2012;13(6):3992.

  • Wong CK, Lam CL, Poon JT, McGhee SM, Law WL, Kwong DL, Tsang J, Chan P. Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective. J Eval Clin Pract. 2012; 18(6): 1203-10.

  • Huang B, Khong PL, Kwong DL, Hung B, Wong CS, Wong CY. Dynamic PET-CT studies for characterizing nasopharyngeal carcinoma metabolism: comparison of analytical methods. Nucl Med Commun 2012; 33(2): 191-7.

  • Kwok H, Tong AH, Lin CH, Lok S, Farrell PJ, Kwong DL, Chiang AK. Genomic sequencing and comparative analysis of epstein-barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PLoS One. 2012;7(5):e36939.

  • Chan MK, Kwong DL, Ng SC, Tam EK, Tong AS. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers. Med Phys. 2012;39(9):5479-87.

  • Tsang RK, Kwong DL, Ho AC, To VS, Ho WK, Wei WI. Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy. ORL J Otorhinolaryngol Relat Spec. 2012;74(4):228-233.

  • Wong CK, Lam CL, Rowen D, McGhee SM, Ma KP, Law WL, Poon JT, Chan P,Kwong DL,Tsang J. Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese Patients with Colorectal Neoplasm. Value Health. 2012;15(3):495-503.

  • Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, Qin YR, Guan XY. MicroRNA-375 inhibits tumor growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012; 61(1): 33-42.

  • Huang B, Chan T, Kwong DL, Chan WK, Khong PL. Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.AJR Am J Roentgenol 2012;199(1):169-74.

  • Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2012; 118(3): 698-710.

  • Chen J, Kwong DL, Zhu CL, Chen LL, Dong SS, Zhang LY, Tian J, Qi CB, Cao TT, Wong AM, Kong KL, Li Y, Liu M, Fu L, Guan XY. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis. PLoS One. 2012;7(9):e44636.

  • Kwong DL. The effect of chemotherapy and radiotherapy on fertility. Hong Kong J Radiol 2012; 15(3): 136-42.

  • Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Lung HL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer. 2012;130(1):83-95.

  • Chen J, Fu L, Zhang LY, Kwong DL, Yan L, Guan XY. Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma. Chin J Cancer 2012;31(5):215-22.

  • Wong CK, Lam CL, Law WL, Poon JT, Chan P, Kwong DL, Tsang J. Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. J Eval Clin Pract. 2012; 18(6): 1186-95.

  • Pow EH, Kwong DL, Sham JS, Lee VH, Ng SC. Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 2012;83(2):e213-221.

  • Lee VH, Ng SC, Choi CW, Luk MY, Leung TW, Au GKH, Kwong DLW. Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves’ ophthalmopathy treated with retro-orbital irradiation. Radiat Oncol 2012 Nov 26;7(1):199

  • Wong CS, Gong N, Chu YC, Anthony MP, Chan Q, Lee HF, Chu KM, Khong PL. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. Eur J Radiol 2012 Sep;81(9):2122-2126.

  • Lee VHF, Ng SCY, Leung TW, Au GKH, Kwong DLW. Dosimetric predictors for radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2012;84(1):176-182.

  • Smith C, Tsang J, Beagley L, Chua D, Lee V, Li V, Moss DJ, Coman W, Chan KH, Nicholls J, Kwong D, Khanna R. Effective treatment of metastatic forms of Epstein-barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. Cancer Res 2012;72(5):1116-1125.

  • Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD 3rd, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Lin D, Chanock SJ, Rothman N. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012 Dec;44(12):1330-1335.

  • Lam KO, Lee VH. Metastatic colorectal cancer: optimizing treatment with anti-EGFR monoclonal antibody. J Cancer Therapy 2012;3:902-911.

  • Lam KO. Evolution of neoadjuvant chemoirradiation in rectal cancer. Hong Kong J Radiol. 2012; 15(Suppl):S33-9

  • Lee AWM,* Tung SY, Chan ATC, Chappell R, Fu YT, Lu TX, Tan T, Chua DTT, O'Sullivan B, Tung R, Ng WT, Leung TW, Leung SF, Yau S, Zhao C, Tan EH, Au GKH, Siu L, Fung KK, Lau WH.A Randomized Trial on Addition of Concurrent-Adjuvant Chemotherapy and/or Accelerated Fractionation for Locally-Advanced Nasopharyngeal Carcinoma. Radiother Oncol, 98(1):15-22, 2011

  • Chang ATY, Ng WT, Law ALY, Ku KM, Lee MCH, Lee AWM. Adjuvant Chemoradiation for Resected Gastric Cancer: A 10-Year Experience. Gastric Cancer, 14(1):63-71 ,2011

  • Choi CW, Lee MCH, Ng WT, Law LY, Yau TK, Lee AWM. An Analysis of the Efficacy of Serial Screening for Familial Nasopharyngeal Carcinoma Based on Markov Chain Models. Familial Cancer, 10(1):133-139, 2011

  • Chan SH, Cheung FMF, Ng WT, Choi CW; Cheung KN, Yiu KH, Lee AWM. Can the Analysis of ERCC1 Expression Contribute to Individualized Therapy in Nasopharyngeal Carcinoma? Int J Radiat Oncol Biol Phys, 79(5):1414-1420, 2011

  • Ng WT, Lee MCH, Hung WM, Choi CW, Lee KC, Chan OSH, Lee AWM. Clinical Outcomes and Patterns of Failure after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys, 79(2):420-428, 2011

  • Lee AWM,* Tung SY, Ngan RKC, Chappell R, Chua DTT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, Leung TW, Fu YT, Au GKH, Zhao C, O'Sullivan B, Tan EH, Lau WH. Factors Contributing to the Efficacy of Concurrent-Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: Combined Analyses of NPC-9901 And NPC-9902 Trials. Eu J Cancer, 47(5):656-666, 2011

  • Chan OSH, Lee MCH, Hung AWM, Chang ATY, Yeung RMW, Lee AWM. The Superiority of Hybrid-Volumetric Arc Therapy (VMAT) Technique over Double Arcs VMAT and 3D-Conformal Technique in the Treatment of Locally Advanced Non-Small Cell Lung Cancer - A Planning Study. Radiother Oncol, 101(2):298-302, 2011

  • Cheng SC, Wu VW, Kwong DL, Ying MT. Assessment of post-radiotherapy salivary glands. Br J Radiol 84 (1001): 393-402, 2011.

  • Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, Chen L, Li Y, Kwong DL, Fu L, Guan XY. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res. 2011;17(1):46-55.

  • Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg 2011; 35(3): 600-7.

  • Cheung AK, Ko JM, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, Tokino T, Kashima L, Suzuki T, Kwong DL, Chua D, Tsao SW, Lung ML. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA 108(20): 8390-5, 2011.

  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient dat for 10,801 women in 17 randomized trials. Lancet 2011; 378(9804): 1707-16.

  • Cheng HC, Wu VW, Liu ES, Kwong DL. Evaluation of radiation dose and image quality for the Varian cone beam computed tomography system. Int J Radiat Oncol Biol Phys 80(1): 291-300, 2011.

  • Wu VW, Ying MT, Kwong DL. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharyngeal carcinoma. Br J Radiol 2011; 84(1005): 843-9.

  • Chan WK, Kwong DL, Yeung DW, Huang B, Khong PL. Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma. Clin Nucl Med 2011; 36(11): 1007-11.

  • Wei WI, Kwong DL. Recurrent nasopharyngeal carcinoma: surgical salvage vs. additional chemoradiation. Curr Opin Otolaryngol Head Neck Surg 19(2): 82-6, 2011.

  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomized trials. Lancet 2011; 378(9793): 771-84.

  • Pow EH, Law MY, Tsang PC, Perera RA, Kwong DL. Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy. Oral Oncol 2011; 47(9): 879-82.

  • Chung Y, Law S, Kwong DL, Luk JM. Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 24(1): 49-55, 2011.

  • Cheng SC, Ying MT, Kwong DL, Wu VW. Sonographic appearance of parotid glands in patients treated with intensity-modulated radiotherapy or conventional radiotherapy for nasopharyngeal carcinoma. Ultrasound Med Biol 37(2): 220-30, 2011.

  • Chan RW, Kang SS, Yen HL, Li AC, Tang LL, Yu WC, Yuen KM, Chan IW, Wong DD, Lai WW, Kwong DL, Sihoe AD, Poon LL, Guan Y, Nicholls JM, Peiris JS, Chan MC. Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J Virol 2011; 85(22) 11581-7.

  • Fu L, Zhang C, Zhang LY, Dong SS, Lu LH, Chen J, Dai Y, Li Y, Kong KL, Kwong DL, Guan XY. Wnt2 secreted by tumor fibroblasts promotes tumor progression in oesophageal cancer by activation of the Wnt/{beta}-catenin signaling pathway. Gut 2011;60(12):1635-43.

  • Tse VC, Ng WT, Lee VHF, Lee AWM, Chua DTT, Chau J, McGhee SH. Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement. BMC Cancer 2011 Jul 9;11:288.

  • Chan YW, Lee VH, Chow VL, To VS, Wei WI. Extracapsular lymph node spread in recurrence nasopharyngeal carcinoma. Laryngoscope 2011;121(12):2576-2580.

  • Ho ACW, Lee VHF, To VSH, Kwong DLW, Wei WI. Natural course and tumor doubling time of nasopharyngeal carcinoma. A study of 15 patients. Oral Oncol 2011;47(8):742-746.

  • Ng DCK, Wong SKH, Ng WT, Lee AWM, Li MKW. Impact of Adjuvant Chemoradiation for Adenocarcinoma of Stomach after Curative Gastrectomy in Chinese: A 7-Year Audit. Surg Practice, 14(3):85-91, 2010

  • Ng WT, Choi CW, Lee MCH, Law LY, Yau TK, Lee AWM. Outcomes of Nasopharyngeal Carcinoma Screening for High Risk Family Members in Hong Kong. Familial Cancer, 9(2):221-228, 2010

  • Lee AWM,* Tung SY, Chua DTT, Ngan RKC, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GKH, Law SCK, O'Sullivan B, Yau TK, Leung TW, Au JSK, Sze WM, Choi CW, Fung KK, Lau JT, Lau WH. Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma. J NCI,102(15):1188-1198, 2010

  • Kong KL, Kwong DL, Fu L, Chan TH, Chen L, Liu H, Li Y, Zhu YH, Bi J, Qin YR, Law SY, Guan XY. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma. Cancer Res 70(21): 8832-41, 2010.

  • Wei WI, Kwong DL. Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol 3(1): 1-12, 2010.

  • Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH. Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17(8): 2184-92, 2010.

  • Chan WK, Mak HK, Huang B, Yueng DW, Kwong DL, Khong PL. Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumor volume and total lesion glycolysis and TNM classification. Nucl Med Commun 31(3): 206-10, 2010.

  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010(41): 162-77, 2010.

  • Kan MW, Leung LH, Kwong DL, Wong W, Lam N. Peripheral doses from noncoplanar IMRT for pediatric radiation therapy. Med Dosim 35(4): 255-63, 2010.

  • Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, Fong JH, Tang LL, Lai WW, Lo AC, Chui WH, Sihoe AD, Kwong DL, Wong DS, Tsao GS, Poon LL, Guan Y, Nicholls JM, Peiris JS. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176(4): 1828-40, 2010.

  • Lee VHF. Shifting the paradigm for maintenance therapy for non-small cell lung cancer. Hong Kong J Radiol 2010;13(Suppl):S16-21.